2-[4-(Aminomethyl)piperidin-1-yl]acetonitrile dihydrochloride

Catalog No.: 
ACLMGA479
CAS No.: 
1354953-43-7
Molecular Formula: 
C8H17Cl2N3
Molecular Weight: 
226.15
2-[4-(Aminomethyl)piperidin-1-yl]acetonitrile dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$117.00In stockInquiry
100mg95%$191.00In stockInquiry
250mg95%$315.00In stockInquiry
1g95%$843.00In stockInquiry
5g95%$3371.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-[4-(Aminomethyl)piperidin-1-yl]acetonitrile dihydrochloride
IUPAC Name2-(4-(aminomethyl)piperidin-1-yl)acetonitrile dihydrochloride
MDL No.MFCD20441556
Molecular FormulaC8H17Cl2N3
Molecular Weight226.15
SMILESN#CCN1CCC(CN)CC1.[H]Cl.[H]Cl
InChI KeyLQVWBOVZEOLNIM-UHFFFAOYSA-N
Synonym2-[4-(aminomethyl)piperidin-1-yl]acetonitrile dihydrochloride
CAS No.1354953-43-7
PubChem CID54595306

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLMGA479 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLMGA479 route product structure diagram
    ACLMGA4791354953-43-7In Stock
Inquiry

2. ACLMGA479 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLMGA479 route product structure diagram
    ACLMGA4791354953-43-7In Stock
Inquiry

3. ACLMGA479 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLMGA479 route product structure diagram
    ACLMGA4791354953-43-7In Stock
Inquiry

Comments (0)